Dream regulates BDNF-dependent spinal sensitization

Molecular Pain

Volumn 6, Issue , 2010, Pages

  Rivera Arconada, Ivan ^a   Benedet, Tomaso ^b   Roza, Carolina ^a   Torres, Begoña ^b   Barrio, Jorge ^b   Krzyzanowska, Agnieszka ^c   Avendaño, Carlos ^c   Mellström, Britt ^b   Lopez Garcia, José A ^a   Naranjo, José R ^b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM ION; CALSENILIN; CYCLIC AMP; PRODYNORPHIN; CSEN PROTEIN, MOUSE; KV CHANNEL INTERACTING PROTEIN; MUTANT PROTEIN; REPRESSOR PROTEIN;

AFFERENT NERVE GROUP 1; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; FUNCTIONAL ELECTRICAL STIMULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; HYPERALGESIA; IN VITRO STUDY; INFLAMMATION; MALE; MOUSE; NERVE FIBER C; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SPINAL CORD; SPINAL CORD STIMULATION; SPINAL GANGLION; SPINAL REFLEX; TRANSGENIC MOUSE; VENTRAL ROOT; WILD TYPE; ANIMAL; DRUG ANTAGONISM; GENETICS; NONMYELINATED NERVE; PAIN; PHYSIOLOGY; RAT;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; GENE EXPRESSION REGULATION; INFLAMMATION; KV CHANNEL-INTERACTING PROTEINS; MICE; MICE, TRANSGENIC; MUTANT PROTEINS; NERVE FIBERS, UNMYELINATED; PAIN; RATS; REPRESSOR PROTEINS; SPINAL CORD;

EID: 78851469601     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-6-95     Document Type: Article

References (47)

1. Carrion AM, Link WA, Ledo F, Mellstrom B, Naranjo JR. DREAM is a Ca2+-regulated transcriptional repressor. Nature 1999, 398:80-84. 10.1038/18044, 10078534.
2. Craig TA, Benson LM, Venyaminov SY, Klimtchuk ES, Bajzer Z, Prendergast FG, Naylor S, Kumar R. The metal-binding properties of DREAM: evidence for calcium-mediated changes in DREAM structure. J Biol Chem 2002, 277:10955-10966. 10.1074/jbc.M109660200, 11788589.
3. Link WA, Ledo F, Torres B, Palczewska M, Madsen TM, Savignac M, Albar JP, Mellstrom B, Naranjo JR. Day-night changes in downstream regulatory element antagonist modulator/potassium channel interacting protein activity contribute to circadian gene expression in pineal gland. J Neurosci 2004, 24:5346-5355. 10.1523/JNEUROSCI.1460-04.2004, 15190107.
4. Osawa M, Tong KI, Lilliehook C, Wasco W, Buxbaum JD, Cheng HY, Penninger JM, Ikura M, Ames JB. Calcium-regulated DNA binding and oligomerization of the neuronal calcium-sensing protein, calsenilin/DREAM/KChIP3. J Biol Chem 2001, 276:41005-41013. 10.1074/jbc.M105842200, 11535596.
5. Ledo F, Carrion AM, Link WA, Mellstrom B, Naranjo JR. DREAM-alphaCREM interaction via leucine-charged domains derepresses downstream regulatory element-dependent transcription. Mol Cell Biol 2000, 20:9120-9126. 10.1128/MCB.20.24.9120-9126.2000, 102170, 11094064.
6. Ledo F, Kremer L, Mellstrom B, Naranjo JR. Ca2+-dependent block of CREB-CBP transcription by repressor DREAM. Embo J 2002, 21:4583-4592. 10.1093/emboj/cdf440, 126180, 12198160.
7. Savignac M, Pintado B, Gutierrez-Adan A, Palczewska M, Mellstrom B, Naranjo JR. Transcriptional repressor DREAM regulates T-lymphocyte proliferation and cytokine gene expression. Embo J 2005, 24:3555-3564. 10.1038/sj.emboj.7600810, 1276700, 16177826.
8. Gomez-Villafuertes R, Torres B, Barrio J, Savignac M, Gabellini N, Rizzato F, Pintado B, Gutierrez-Adan A, Mellstrom B, Carafoli E, Naranjo JR. Downstream regulatory element antagonist modulator regulates Ca2+ homeostasis and viability in cerebellar neurons. J Neurosci 2005, 25:10822-10830. 10.1523/JNEUROSCI.3912-05.2005, 16306395.
9. Mellstrom B, Torres B, Link WA, Naranjo JR. The BDNF gene: exemplifying complexity in Ca2+ -dependent gene expression. Crit Rev Neurobiol 2004, 16:43-49. 10.1615/CritRevNeurobiol.v16.i12.40, 15581398.
10. Buxbaum JD, Choi EK, Luo Y, Lilliehook C, Crowley AC, Merriam DE, Wasco W. Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nat Med 1998, 4:1177-1181. 10.1038/2673, 9771752.
11. An WF, Bowlby MR, Betty M, Cao J, Ling HP, Mendoza G, Hinson JW, Mattsson KI, Strassle BW, Trimmer JS, Rhodes KJ. Modulation of A-type potassium channels by a family of calcium sensors. Nature 2000, 403:553-556. 10.1038/35000592, 10676964.
12. Cheng HY, Pitcher GM, Laviolette SR, Whishaw IQ, Tong KI, Kockeritz LK, Wada T, Joza NA, Crackower M, Goncalves J, et al. DREAM is a critical transcriptional repressor for pain modulation. Cell 2002, 108:31-43. 10.1016/S0092-8674(01)00629-8, 11792319.
13. Lilliehook C, Bozdagi O, Yao J, Gomez-Ramirez M, Zaidi NF, Wasco W, Gandy S, Santucci AC, Haroutunian V, Huntley GW, Buxbaum JD. Altered Abeta formation and long-term potentiation in a calsenilin knock-out. J Neurosci 2003, 23:9097-9106.
14. Alexander JC, McDermott CM, Tunur T, Rands V, Stelly C, Karhson D, Bowlby MR, An WF, Sweatt JD, Schrader LA. The role of calsenilin/DREAM/KChIP3 in contextual fear conditioning. Learn Mem 2009, 16:167-177. 10.1101/lm.1261709, 2661250, 19223600.
15. Hu HJ, Carrasquillo Y, Karim F, Jung WE, Nerbonne JM, Schwarz TL, Gereau R. The kv4.2 potassium channel subunit is required for pain plasticity. Neuron 2006, 50:89-100. 10.1016/j.neuron.2006.03.010, 16600858.
16. Kerr BJ, Bradbury EJ, Bennett DL, Trivedi PM, Dassan P, French J, Shelton DB, McMahon SB, Thompson SW. Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord. J Neurosci 1999, 19:5138-5148.
17. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, De Koninck Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438:1017-1021. 10.1038/nature04223, 16355225.
18. Jones KR, Farinas I, Backus C, Reichardt LF. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 1994, 76:989-999. 10.1016/0092-8674(94)90377-8, 2711896, 8137432.
19. Liu X, Ernfors P, Wu H, Jaenisch R. Sensory but not motor neuron deficits in mice lacking NT4 and BDNF. Nature 1995, 375:238-241. 10.1038/375238a0, 7746325.
20. Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T. Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 2007, 85:525-535. 10.1002/jnr.21139, 1878509,1878509, 17149751.
21. Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME. Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 1998, 20:709-726. 10.1016/S0896-6273(00)81010-7, 9581763.
22. Shieh PB, Hu SC, Bobb K, Timmusk T, Ghosh A. Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 1998, 20:727-740. 10.1016/S0896-6273(00)81011-9, 9581764.
23. Tao X, West AE, Chen WG, Corfas G, Greenberg ME. A calcium-responsive transcription factor, CaRF, that regulates neuronal activity-dependent expression of BDNF. Neuron 2002, 33:383-395. 10.1016/S0896-6273(01)00561-X, 11832226.
24. Hedo G, Laird JM, Lopez-Garcia JA. Time-course of spinal sensitization following carrageenan-induced inflammation in the young rat: a comparative electrophysiological and behavioural study in vitro and in vivo. Neuroscience 1999, 92:309-318. 10.1016/S0306-4522(98)00734-9, 10392852.
25. Mayford M, Bach ME, Huang YY, Wang L, Hawkins RD, Kandel ER. Control of memory formation through regulated expression of a CaMKII transgene. Science 1996, 274:1678-1683. 10.1126/science.274.5293.1678, 8939850.
26. Martinez-Gomez J, Lopez-Garcia JA. Electrophysiological and pharmacological characterisation of ascending anterolateral axons in the in vitro mouse spinal cord. J Neurosci Methods 2005, 146:84-90. 10.1016/j.jneumeth.2005.01.015, 15935224.
27. Frick A, Magee J, Johnston D. LTP is accompanied by an enhanced local excitability of pyramidal neuron dendrites. Nat Neurosci 2004, 7:126-135. 10.1038/nn1178, 14730307.
28. Ikeda H, Tsuda M, Inoue K, Murase K. Long-term potentiation of neuronal excitation by neuron-glia interactions in the rat spinal dorsal horn. Eur J Neurosci 2007, 25:1297-1306. 10.1111/j.1460-9568.2007.05386.x, 17425556.
29. Groth R, Aanonsen L. Spinal brain-derived neurotrophic factor (BDNF) produces hyperalgesia in normal mice while antisense directed against either BDNF or trkB, prevent inflammation-induced hyperalgesia. Pain 2002, 100:171-181. 10.1016/S0304-3959(02)00264-6, 12435470.
30. Wu LJ, Mellstrom B, Wang H, Ren M, Domingo S, Kim SS, Li XY, Chen T, Naranjo JR, Zhuo M. DREAM (Downstream Regulatory Element Antagonist Modulator) contributes to synaptic depression and contextual fear memory. Mol Brain 3:3. 10.1186/1756-6606-3-3, 2822766, 20205763.
31. Ren K, Dubner R. Pain facilitation and activity-dependent plasticity in pain modulatory circuitry: role of BDNF-TrkB signaling and NMDA receptors. Mol Neurobiol 2007, 35:224-235. 10.1007/s12035-007-0028-8, 17917111.
32. Zhang Y, Su P, Liang P, Liu T, Liu X, Liu XY, Zhang B, Han T, Zhu YB, Yin DM, et al. The DREAM protein negatively regulates the NMDA receptor through interaction with the NR1 subunit. J Neurosci 30:7575-7586. 10.1523/JNEUROSCI.1312-10.2010, 20519532.
33. Wagner JJ, Terman GW, Chavkin C. Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature 1993, 363:451-454. 10.1038/363451a0, 2096733, 8099201.
34. Menegola M, Trimmer JS. Unanticipated region- and cell-specific downregulation of individual KChIP auxiliary subunit isotypes in Kv4.2 knock-out mouse brain. J Neurosci 2006, 26:12137-12142. 10.1523/JNEUROSCI.2783-06.2006, 17122038.
35. Sandkuhler J. Understanding LTP in pain pathways. Mol Pain 2007, 3:9. 10.1186/1744-8069-3-9, 1852298, 17407590.
36. Matayoshi S, Jiang N, Katafuchi T, Koga K, Furue H, Yasaka T, Nakatsuka T, Zhou XF, Kawasaki Y, Tanaka N, Yoshimura M. Actions of brain-derived neurotrophic factor on spinal nociceptive transmission during inflammation in the rat. J Physiol 2005, 569:685-695. 10.1113/jphysiol.2005.095331, 1464224, 16210356.
37. Zhao J, Seereeram A, Nassar MA, Levato A, Pezet S, Hathaway G, Morenilla-Palao C, Stirling C, Fitzgerald M, McMahon SB, et al. Nociceptor-derived brain-derived neurotrophic factor regulates acute and inflammatory but not neuropathic pain. Mol Cell Neurosci 2006, 31:539-548. 10.1016/j.mcn.2005.11.008, 16413788.
38. Heppenstall PA, Lewin GR. BDNF but not NT-4 is required for normal flexion reflex plasticity and function. Proc Natl Acad Sci USA 2001, 98:8107-8112. 10.1073/pnas.141015098, 35475, 11438749.
39. Garraway SM, Petruska JC, Mendell LM. BDNF sensitizes the response of lamina II neurons to high threshold primary afferent inputs. Eur J Neurosci 2003, 18:2467-2476. 10.1046/j.1460-9568.2003.02982.x, 14622147.
40. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988, 32:77-88. 10.1016/0304-3959(88)90026-7, 3340425.
41. Taber RI, Greenhouse DD, Rendell JK, Irwin S. Agonist and antagonist interactions of opioids on acetic acid-induced abdominal stretching in mice. J Pharmacol Exp Ther 1969, 169:29-38.
42. Taylor J, Mellstrom B, Fernaud I, Naranjo JR. Metamizol potentiates morphine effects on visceral pain and evoked c-Fos immunoreactivity in spinal cord. Eur J Pharmacol 1998, 351:39-47. 10.1016/S0014-2999(98)00298-2, 9698203.
43. Rivera-Arconada I, Lopez-Garcia JA. Effects of M-current modulators on the excitability of immature rat spinal sensory and motor neurones. Eur J Neurosci 2005, 22:3091-3098. 10.1111/j.1460-9568.2005.04507.x, 16367775.
44. Hedo G, Lopez-Garcia JA. Alpha-1A adrenoceptors modulate potentiation of spinal nociceptive pathways in the rat spinal cord in vitro. Neuropharmacology 2001, 41:862-869. 10.1016/S0028-3908(01)00117-4, 11684150.
45. Rivera-Arconada I, Lopez-Garcia JA. Changes in membrane excitability and potassium currents in sensitized dorsal horn neurons of mice pups. J Neurosci 30:5376-5383. 10.1523/JNEUROSCI.4359-09.2010, 20392959.
46. Hu HJ, Glauner KS, Gereau R. ERK integrates PKA and PKC signaling in superficial dorsal horn neurons. I. Modulation of A-type K+ currents. J Neurophysiol 2003, 90:1671-1679. 10.1152/jn.00340.2003, 12750419.
47. Jerng HH, Pfaffinger PJ, Covarrubias M. Molecular physiology and modulation of somatodendritic A-type potassium channels. Mol Cell Neurosci 2004, 27:343-369. 10.1016/j.mcn.2004.06.011, 15555915.